Pharvaris N.V.

Factors to consider:

• Total employees count: 14 as of 2020
• Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [16.36$, 40.25$]
• 2026-12-31 to 2027-12-31 estimated range: [12.45$, 31.96$]

Financial Metrics affecting the PHVS estimates:

• Negative: with PPE of -7.6 at the end of fiscal year the price was high
• Negative: negative Operating income
• Negative: Operating cash flow per share per price, % of -10.55 <= 0.07
• Positive: Investing cash flow per share per price, % of -0.01 > -0.65
• Positive: Interest expense per share per price, % of 0 <= 0.01
• Positive: Shareholder equity ratio, % of 89.99 > 64.25
• Positive: Inventory ratio change, % of 0 <= 0
• Negative: negative Industry operating cash flow (median)